Time Tested Since 1971
Cart 0

News

New IV Drug Compatibility & Stability for Summer 2020

Summer 2020 This is the 216th quarterly update to the King® Guide to Parenteral Admixtures® Online & Loose-Leaf Editions. New Monograph GLUCAGON New Stability Information  ALPROSTADIL, ALTEPLASE, CEFOTAXIME, CEFTOLOZANE AND TAZOBACTAM, COLISTIMETHATE SODIUM, DIAZEPAM, FLUOROURACIL, IBUPROFEN, ISOSORBIDE DINITRATE, MEROPENEM AND VABORBACTAM, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, TORSEMIDE, VANCOMYCIN HYDROCHLORIDE, and VORICONAZOLE. New Compatibility Information CIPROFLOXACIN, FUROSEMIDE, IBUPROFEN, INSULIN, REGULAR, KETAMINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE, LINEZOLIDE, MEROPENEM, PERITONEAL DIALYSIS SOLUTIONS, PROPOFOL, REMIFENTANIL HYDROCHLORIDE, TOTAL PARENTERAL NUTRITION SOLUTIONS, and VANCOMYCIN HYDROCHLORIDE.   

Read more →


Spring 2020 Update

We added new stability information to these existing drug monographs:  BUPRENORPHINE HYDROCHLORIDE, CEFUROXIME SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, ERAVACYCLINE, and FUROSEMIDE. In addition, new compatibility information is reported for ERAVACYCLINE with 51 other drugs. 

Read more →


2020 Y-Site Compatibility Wall Charts

Y-Site Compatibility Wall Charts Updated for 2020 King Guide Y-Site Compatibility Wall Charts include 123 IV drugs in 4 infusion fluids. Critical Care Admixtures We added 'Oxytocin' Updated with compatibility data published in the King Guide to Parenteral Admixtures for 2019 Available in English or French Laminated 27" x 27" poster Chemotherapy Admixtures Updated with compatibility data published in the King Guide to Parenteral Admixtures for 2019 Available in English Laminated 27" x 27" poster  

Read more →


Winter 2019 New & Updated IV Compatibility & Stability

Our Winter 2019 update includes 8 new drugs, new stability information for 9 drugs, and new compatibility information for 14 drugs.

Read more →


Fall 2019 New & Updated IV Compatibility and Stability

In this update we added a new drug monograph for DALBAVANCIN. We added new stability information to the existing drug monographs for AMIODARONE HYDROCHLORIDE, CARBOPLATIN, CEFAZOLIN SODIUM, CEFTAZIDIME, INFLIXIMAB, MEROPENEM, METHOTRIMEPRAZINE HYDROCHLORIDE, PIPERACILLIN and TAZOBACTAM, AND SODIUM THIOSULFATE. In addition, new compatibility information is reported for these drugs:  ACETAMINOPHEN, AMPICILLIN SODIUM, AMPICILLIN SODIUM – SULBACTAM SODIUM, BLINATUMOMAB, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE PHOSPHATE, FENTANYL CITRATE, FOSPHENYTOIN SODIUM, FUROSEMIDE, HALOPERIDOL LACTATE, HYDROMORPHONE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, KETOPROFEN, LIDOCAINE HYDROCHLORIDE, MAGNESIUM SULFATE, METRONIDAZOLE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, RASBURICASE, SUGAMMADEX, TOTAL PARENTERAL NUTRITION SOLUTIONS, VINCRISTINE SULFATE, and VORICONAZOLE.

Read more →